Novo Nordisk sued for allegedly monopolising diabetes drug Victoza
Victoza, approved by the US Food and Drug Administration in 2010, was Novo’s first-generation blockbuster GLP-1 drug
Victoza, approved by the US Food and Drug Administration in 2010, was Novo’s first-generation blockbuster GLP-1 drug